EV/EBITDA
0.72
+0.01+1.41%
Fri, 21 Feb 2025 22:27:07 GMT
Summary
- As of February 23, 2025, CNTX EV/EBITDA is 0.72, with a rise of +0.01 (+1.41%) during the most recent trading day.
- Over the past year, CNTX EV/EBITDA has increased by +1.04 (+325.00%).
- CNTX EV/EBITDA is now -66.36% below its all-time high of 2.14.
Performance
CNTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CNTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.4% | -1.6% | -0.6% |
| 1 m1 month | +75.6% | -76.3% | -14.2% |
| 3 m3 months | +241.2% | -240.5% | -39.6% |
| 6 m6 months | +116.6% | -127.0% | -67.5% |
| ytdytd | +300.0% | -303.4% | -22.4% |
| 1 y1 year | +325.0% | -396.5% | -41.8% |
| 5 y5 years | - | - | - |
CNTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.0% | 0.29 | +148.3% | |
| 3 m | 3-month | 0.80 | -10.0% | -1.07 | +167.3% |
| 6 m | 6-month | 0.80 | -10.0% | -4.33 | +116.6% |
| 1 y | 1-year | 0.80 | -10.0% | -6.97 | +110.3% |
| 3 y | 3-year | 2.14 | -66.4% | -6.97 | +110.3% |
| 5 y | 5-year | 2.14 | -66.4% | -19.76 | +103.6% |
| alltime | all time | 2.14 | -66.4% | -19.76 | +103.6% |
Context Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.72(+300.0%) |
| 2024 | 0.18(-228.6%) |
| Date | Value |
|---|---|
| 2023 | -0.14(-108.2%) |
| 2022 | 1.70(+146.4%) |
| 2021 | 0.69 |
FAQ
- What is Context Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Context Therapeutics?
- What is CNTX EV/EBITDA year-to-date change?
- What is Context Therapeutics EV/EBITDA year-on-year change?
What is Context Therapeutics EV/EBITDA?
The current EV/EBITDA of CNTX is 0.72
What is the all time high EV/EBITDA for Context Therapeutics?
Context Therapeutics all-time high EV/EBITDA is 2.14
What is CNTX EV/EBITDA year-to-date change?
Context Therapeutics EV/EBITDA has changed by +0.54 (+300.00%) since the beginning of the year
What is Context Therapeutics EV/EBITDA year-on-year change?
Over the past year, CNTX EV/EBITDA has changed by +1.04 (+325.00%)